Menu

Experience

Ivor Elrifi

    • Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche 


    • Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II 


    • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 


    • Exscientia – $510.4 Million IPO 


    • Ovid - $75 Million IPO 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering 


    • Vir Biotechnology - $143 Million IPO 


    • Therachon Sells to Pfizer for up to $810 Million 


    • ERYTECH – $144 Million IPO 


    • Cooley Advises on Nightstar + NuCana IPOs 


    • Recro Pharma – $15 Million Follow-On  


    • Syros – $58 Million IPO 


    • Syros IPO – $58 Million 


    • Selecta Biosciences – $74 Million IPO 


    • Oncobiologics – $40 Million IPO and Private Placement 


    • AveXis – $95 Million IPO 


    • WAVE Life Sciences - $102 Million IPO 


    • Voyager Therapeutics - $80.5 Million IPO 


    • Catabasis Completes $69 Million IPO 


    • Axovant Completes $362 Million IPO 


    • OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals 


    • Minerva – $58 Million Follow-On Offering